IMM 4.69% 33.5¢ immutep limited

News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement

  1. 191,533 Posts.
    lightbulb Created with Sketch. 2808

    Sept 24 (Reuters) - Immutep Ltd (IMM) :

    • ENTERED INTO A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK KGAA AND PFIZER INC
    • TRIAL TO EVALUATE COMBINATION OF IMMUTEP'S IMMUNOTHERAPY PRODUCT CANDIDATE WITH AVELUMAB*, A HUMAN ANTI-PD-L1 ANTIBODY

    Source text: (http//bit.ly/2MY1iYH)

    (([email protected];))

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
33.5¢
Change
0.015(4.69%)
Mkt cap ! $486.6M
Open High Low Value Volume
32.0¢ 33.5¢ 32.0¢ $1.303M 3.974M

Buyers (Bids)

No. Vol. Price($)
6 29843 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 105523 4
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.